Skip to main content
Back
Watch Compare

HeartSciences Inc.

Data quality: 100%
Also listed as HSCSW Nasdaq
HSCS
Nasdaq Manufacturing Measuring & Analyzing Instruments
$2.16
▼ $0.09 (-4.00%)
Mkt Cap: 6.88 M
Price
$2.16
Mkt Cap
6.88 M
Day Range
$2.16 — $2.29
52-Week Range
$2.01 — $6.47
Volume
11,188
Open $2.29
50D / 200D Avg
$2.78
22.42% below
50D / 200D Avg
$3.19
32.24% below

Quick Summary

Key Takeaways

Net margin of 229705.35% shows strong profitability
Negative free cash flow of -11.65 M
Capital efficient — spends only -295.51% of revenue on capex

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)-76.61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-580.83%
Below sector avg (-53.41%)
ROIC-342.48%
Net Margin229705.35%
Op. Margin209272.68%

Safety

Debt / Equity
N/A
Current Ratio1.19
Interest Coverage-10.05

Valuation

PE (TTM)
-0.53
Above sector avg (-1.48)
P/B Ratio2.59
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.5 -1.5
P/B 2.6 1.6
ROE % -580.8 -53.4
Net Margin % 229705.4 -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -76.61% Revenue Growth (3Y) -8.09%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) -5,612.0 Net Income (TTM) -12.89 M
ROE -580.83% ROA -194.46%
Gross Margin 88.15% Operating Margin 209272.68%
Net Margin 229705.35% Free Cash Flow (TTM) -11.65 M
ROIC -342.48% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.19
Interest Coverage -10.05 Asset Turnover 0.00
Working Capital 829,925 Tangible Book Value 994,948
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.53 Forward P/E N/A
P/B Ratio 2.59 P/S Ratio -1225.76
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -169.28%
Market Cap 6.88 M Enterprise Value 3.48 M
Per Share
EPS (Diluted TTM) -3.98 Revenue / Share 0.00
FCF / Share -3.66 OCF / Share -3.65
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue -295.51% FCF Conversion 90.33%
SBC-Adj. FCF -12.79 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 4,350.0 18,600.0 5,150.0
Net Income -8.77 M -6.61 M -6.35 M
EPS (Diluted) -9.34 -19.00 -0.80
Gross Profit 2,470.0 12,519.0 2,354.0
Operating Income -8.35 M -6.31 M -6.11 M
EBITDA — — —
R&D Expenses 4.39 M 2.88 M 2.46 M
SG&A Expenses 3.97 M 3.44 M 3.65 M
D&A — — —
Interest Expense 500,453.0 354,080.0 243,174.0
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 4.22 M 9.50 M 3.29 M
Total Liabilities 4.02 M 2.19 M 3.06 M
Shareholders' Equity 205,171.0 7.32 M 230,557.0
Total Debt — — —
Cash & Equivalents 1.10 M 5.81 M 1.66 M
Current Assets 2.17 M 7.35 M 2.70 M
Current Liabilities 3.70 M 1.75 M 1.83 M